KATHLEEN DIPIETRO: Open Payments
NPI 1558926352 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 45 payments from 13 companies in 2025. Trend: 2023 $1,214 · 2024 $906 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $833 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Gilead Sciences, Inc. | 1 | $28 |
| QOL Medical, LLC | 1 | $25 |
| Ardelyx, Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $20 |
| VIVUS LLC | 1 | $19 |
| Celltrion USA Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $15 |
Products named: SKYRIZI, RINVOQ, LINZESS, CREON, ENTYVIO, Sucraid, IBSRELA, TREMFYA.
Industry payments across OH — which companies pay providers there.
